ETF Quote Details
|NAV (month end)||68.62|
|Premium (+)/Discount (-) (month end)||-1.26|
Zacks Premium Research for FBT
|Zacks ETF Rank [?]||Strong Buy 1|
|ETF Risk [?]||High|
|ETF Research Report|
Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.
This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:
Zacks Premium - The only way to get access to the Zacks Rank
ETF Expense Ratio
|Dividend (Yield)||$0.00 (0.00%)|
|Issuer||FIRST TRUST ADVISORS|
This Index is an equal dollar weighted index designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. Eg, recombinant DNA technology, molecular biology, genetic engineering, monoclonal antibody-based technology, lipid/liposome technology, and genomics.
This Fund is an exchange-traded index fund or Index ETF which is a separate investment portfolio of the First Trust Exchange-Traded Fund, an open-end management investment company. The First Trust NYSE Arca Biotechnology Index Fund seeks investment results that correspond generally to the price and yield, before fees and expenses, of the NYSE Arca Biotechnology Index.